Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests if talking about racism can improve black Women's heart health

NCT ID NCT05902741

Symptom relief Sponsor: Loyola University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study tests a program called RiSE that helps African American women cope with race-based stress. Researchers want to see if it improves well-being, reduces inflammation, and changes DNA markers. 300 post-menopausal women aged 50-75 with heart or metabolic risk factors will join either the RiSE program or a general health education class for 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RiSE (Resilience, Stress, and Ethnicity) program
What this could lead to
If it works, this program could offer a way to reduce stress and improve health in African American women facing race-based stress.
What could go wrong
This is a small, early-stage study testing a behavioral program, so results may not be generalizable. The benefits may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Between the ages of 50 and 75 * Female * Post-menopausal (without menstrual period for at least 12 consecutive months) * Self-identified AA or Black * Able to write, read, speak English * Must have at least 1 of any of the following: * Waist circumference \>88 cm * Systolic BP\>130 mmHg and/ or diastolic BP\>88 mmHg or on antihypertensive medications * Diagnosed and/or being treated for hypercholesterolemia * History of Type 2 diabetes Exclusion Criteria: * History of myocardial infarction or ischemic heart disease/angina, stent placement, coronary artery bypass, left ventricular hypertrophy, congestive heart failure, or ischemic stroke * Any major immune-related disease (e.g., rheumatoid arthritis. lupus) * Use of immune-altering medications, such as glucocorticoids * Periodontal disease, bleeding gums, dental work in past 72 hours * Current smoker or has smoked in past 3 months * Active cancer * Active infection * Substance abuse * Cognitive or psychiatric disorder that would affect ability to participate in classes (Brief Screen for Cognitive Impairment total score of 8 or higher)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inflammation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease Racism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inflammation RACISM Stress

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Loyola University Chicago

    RECRUITING

    Maywood, Illinois, 60153, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.